Compare BioNTech SE - ADR (BNTX) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Eli Lilly And Co — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Eli Lilly And Co trades at $1,211.28 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 46.3× BioNTech SE - ADR's market cap, and Eli Lilly And Co pays a 0.57% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | LLY | |
|---|---|---|
Market Cap | $23.31B | $1.08T |
Sector | Health | Health |
52-Week High | $119.34 | $1.24K |
52-Week Low | $83.89 | $639.43 |
Enterprise Value | $6.60B | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
